5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow Sunovion Respiratory Development Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD Placebo, SUN101 3 mcg, SUN-101 6.25 mcg - COPD | Phase 2 | Completed | Sunovion Respiratory Development Inc. | 96 | 2014-01-01 | 2018-04-10 |
| A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease Placebo, EP-101 12.5 mcg, EP-101 25 mcg - COPD | Phase 2 | Completed | Sunovion Respiratory Development Inc. | 275 | 2012-10-01 | 2018-03-08 |
| Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study EP-101 via nebulizer (eFlow®) 25 ug, EP-101 via nebulizer (eFlow®) 50 ug, EP-101 via nebulizer (eFlow®) 100 ug - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Sunovion Respiratory Development Inc. | 140 | 2011-08-01 | 2018-05-09 |
| Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD) Glycopyrrolate Inhalation Solution12.5μg, Glycopyrrolate Inhalation Solution 50μg, Glycopyrrolate Inhalation Solution 100μg - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Sunovion Respiratory Development Inc. | 42 | 2010-07-01 | 2018-03-12 |
| Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [ie, Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered With an Electronic eFlow Nebulizer System in Patients With Chronic Obstructive Pulmonary Disease (COPD) Glycopyrrolate Inhalation Solution 25mg, Glycopyrrolate Inhalation Solution 75mg, Glycopyrrolate Inhalation Solution 200mg - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Sunovion Respiratory Development Inc. | 12 | 2009-05-01 | 2018-04-30 |
Pulmonary Disease, Chronic Obstructive (5) · Bronchitis, Chronic (2) · Emphysema (2)
Ipratropium (1) · Tiotropium Bromide (1) · aclidinium bromide (1)
United States (3) · United Kingdom (1)
Ahmet Tutuncu, MD, PhD (2) · Ahmet Tutuncu, M.D., Ph.D. (1)
2009 (1)